FEB 09, 2017 12:48 PM PST

New Mechanism For How Aspirin Fights Cancer

WRITTEN BY: Xuan Pham

Aspirin, the ultra-cheap drug that’s ubiquitous in nearly everyone’s medicine cabinet, has a long been implicated as an anticancer drug. Strangely, however, the mechanisms of its purported anticancer effects have always been vague. Now, scientists say that it’s not the anti-inflammatory power of aspirin that thwarts cancer; rather, they think it’s because of aspirin’s effects on blood clotting.

Formally known as acetylsalicylic acid (ASA), aspirin is one of the cheapest and most widely used over-the-counter drugs. This humble drug is used to treat a variety of health conditions like the common fevers, headaches, and inflammation. Doctors also prescribe this drug to reduce the risk of heart attacks for patients who have already had one.

In recent years, aspirin gained the spotlight again as more research linked it to anti-cancer potential. Studies have previously linked aspirin to lowering the risks for colorectal and colon cancer by close to 20 percent.

As to why aspirin is such a miracle drug, researchers typically point out its anti-inflammatory properties. But in examining the mechanism behind aspirin’s effects, researchers at the Veteran’s Affairs in Texas found that aspirin may also affect platelets –blood cells that form clots to protect against bleeding out.

In particular, the team studied aspirin’s effects in cell cultures and mice. They found that ASA reduced the level of COX-1, an enzyme that revs up the body’s inflammatory responses. As a result, less platelets are able to circulate in the bloodstream, which reduces the chances of interaction between platelets and cancer cells.

As the team reports, platelets are useful in stopping bleeding. However, cancer can subvert these cells for its own growth. Thus, reducing platelet circulation may be the mechanism behind how aspirin lowers cancer risks.

"These results suggest that aspirin's chemopreventive effects may be due, in part, to the drug blocking the proneoplastic [supporting new, abnormal growth, as in cancer] action of platelets and [they support] the potential use of Aspirin-PC/PL2200 as an effective and safer chemopreventive agent for colorectal cancer and possibly other cancers,” the team reported in Cancer Prevention Research.

The team will next test aspirin’s safety and efficacy in people with colorectal cancer. In the mean time, they say the results "support the use of low-dose aspirin for chemoprevention."

So, does an aspirin a day keep cancer at bay? You and your doctor decide.

Additional sources: Veterans Affairs Research Communications

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 19, 2018
Cancer
JUN 19, 2018
Malignant Glioma Growth Patterns Leave Hippocampus Unaffected
Malignant glioma has specific invasive patterns of growth within the brain; one structure avoided by tumor cells is the hippocampus....
JUL 10, 2018
Cancer
JUL 10, 2018
TdT Positive Cells - Not Just for Neoplasms
TdT positive cells are associated with early lymphoid neoplasms but healthy lymphoid precursors can also be positive, especially in pediatric patient lymph nodes....
AUG 07, 2018
Cancer
AUG 07, 2018
Potential Bcl-2 Targeted Therapy for Relapsed Multiple Myeloma Patients
Targeted therapy for Bcl-2 may be helpful in more than the two lymphoma diagnoses that were recently approved by the FDA....
SEP 04, 2018
Cancer
SEP 04, 2018
Metal beads that could help reduce chemotherapy side effects in brain tumor
Brain tumors are one of the most challenging types of cancers to treat. Only 1 in 7 patients will survive the disease, and those survivors will usually suffer from lots of side effects becaus...
OCT 07, 2018
Videos
OCT 07, 2018
Certain Foods Encourage a Gut Microbe, and Colon Cancer
Researchers reveal more evidence that refined grains and sugars and processed meats are bad for colon health....
OCT 14, 2018
Immunology
OCT 14, 2018
The Stem of Cancer
Scientists reveal a pathway involved in cancer cell ability to act as stem cells...
Loading Comments...